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We encountered a patient with hemolytic uremic syndrome (HUS) with persistent 
isolation of shiga toxin-producing Escherichia coli (STEC) for 3 weeks despite of 
having no clinical symptoms. STEC has been recognized as an important food-
borne pathogen that causes severe diseases such as HUS. We characterized this 
STEC strain via a polymerase chain reaction, reverse-passive latex agglutination   
and the slide agglutination method. In this STEC strain, stx2 (shiga toxin), eaeA, tir, 
iha (adherence genes), espADB (type III secretion genes), and hlyA, ehxA, clyA 
(hemolysin genes) were present. The O antigen of the strain was non-typable.
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INTRODUCTION
Shiga toxin-producing Escherichia coli (STEC) O157:H7 has been recognized as 
an important food-borne pathogen that causes severe diseases such as a hemolytic 
uremic syndrome (HUS).1 The majority of cases of this disease are caused by 
strains of the serotype O157:H7, but infections by enterohemorrhagic Escherichia 
coli (EHEC) strains belonging to serogroups other than O157, such as O26, O103, 
O111and O145, have been reported with increasing frequency.1,2
Shiga toxins (stxs) are the virulence factor of EHEC. The two groups consist of 
stx1 and stx2.3 Apart from stxs, there are various virulence factors of EHEC, eae 
(Intimin), tir (translocated intimin receptor), hlyA (EHEC hemolysin), and espADB 
(type III secretion proteins).1,4 The locus for enterocyte effacement (LEE) is asso-
ciated with intimate adherence to epithelial cells.5 Several protein were proposed 
to be adhesion factors in LEE-negative strains, including iha (an adherence-con-
ferring protein),6 efa1 (an EHEC factor for adherence),7 Saa (an autoagglutinating 
adhesin)8 and toxB (a protein from 93-kbplasmid pO157), which are required for 
O157:H7 strain Sakai expression of adherence.9 E. coli hemolysin (hlyA), entero-
hemorrhagic E. coli toxin (ehx) and cytolysin A (clyA) are well known as repeats 
in the toxin (RTX) family.10-12
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genes, eaeA and tir genes and non-LEE adhesion genes 
such as the iha, saa, efa1 and toxB genes, were analyzed in 
the STEC strain. The eaeA, tir, and iha genes were present 
in the strain (Table 1). All the genes tested for type III se-
cretion proteins, i.e., espADB were found in the strain in 
the PCR analysis. PCR analysis showed that the hlyA, 
ehxA, and clyA genes for hemolysin production were de-
tected in the strain (Table 1).
The presence of O antigens was determined by slide ag-
glutination with the available O (O1-O181) antisera (Uni-
versidad de Santiago de Compostela, Lugo, Spain).13 We 
performed serotyping of the stain with the antisera. Howev-
er, the serotype of the strain was non-typable with the tested 
antisera.
Antimicrobial susceptibility of the isolate to the following 
16 antibiotics was determined by agar disk diffusion (Kirby-
Bauer method) using Mueller-Hinton agar (Difco) : ampi-
cillin/sulbactam (SAM), ampicillin (AM), tetracycline 
(TE), aztreonam (ATM), cefotetan (CTT), cefepime (FEP), 
cefoxitin (FOX), cefotaxime (CTX), tobramycin (NN), tri-
methoprim/sulfamethoxazole (SXT/TM), cephalothin (CF), 
imipenem (IPM), gentamicin (GM), amikacin (AN), piper-
acillin/tazobactam (TZP), netilamicin (NET). E. coli ATCC 
25922 and E. coli ATCC 35218 were used as quality con-
trols. As shown in Table 2, the isolate showed  resistance to 
Ampicillin, Tetracycline and Trimethoprim-sulfamethoxa-
zole, while it was sensible to two antibiotics of β-lactam/
β-lactamase inhibitor combinations and Imipenem. Among 
the Cephems, the isolate showed resistance only to Cepha-
lothin. On hospital day (HD) 17, cefuroxime was started 
due to persistent STEC isolation. On HD38, cefepime was 
started for four days. On HD 49, she was discharged after 
having negative results for stool STEC isolation for a week. 
DISCUSSION
In the present study, we characterized the virulence genes 
of the STEC strain. Our results showed that the strain in 
this study possessed many virulent factors for infection, for 
example, toxins, adhesins and hemolysins.
The Shiga-toxin genotype of the infecting strain may in-
fluence the risk of developing microangiopathic sequelae 
and the outcome of infection. Patients infected with STEC 
0157 possessing stx2 but not stx1 had significantly devel-
oped systemic sequelae, including HUS, than patients in-
fected with STEC 0157 harboring stx1 alone or both stx1 
to long-term isolation of STEC. We conducted molecular and 
serotype analyses on this patient.  
CASE REPORT
A three-year-old child was admitted to Uijeongbu St. Mary’s 
Hospital with abdominal pain and watery/bloody diarrhea 
3-4 days after eating boiled fish paste. Physical examination 
upon admission was unremarkable. The abdomen computer-
ized tomography image showed prominent submucosal 
edema of the total colon. Hematological tests revealed-: he-
moglobin 12.6 g/dL, leukocyte count 43.5×109/L with neu-
trophilia (90%), platelet count 33×109/L. The results of a 
blood chemistry study of the serum samples were blood 
urea nitrogen, 39.1 mg/dL, albumin 1.7 g/dL and CRP 5.03 
mg/dL. The serum creatinine level was increased from 0.44 
mg/dL to 2.33 mg/dL. Urinalysis showed four positive tests 
for hematuria and proteinuria. A diagnosis of HUS was 
made and the patient was transferred to another hospital, 
where she underwent hemodialysis.  
She was admitted to our hospital a second time due to 
persistent STEC isolation, although her clinical symptoms 
were improved. We isolated the STEC strain from the pa-
tient’s stool.  However, no other pathogenic bacteria such as 
Salmonella spp., Shigella spp., and Vibrio spp. were detect-
ed in the stool. The isolate was biochemically characterized 
using the API20E system (Biomerieux, Marcy l’Etoile, 
France). The isolate was directly inoculated into 3 mL of 
Luria-Bertani (LB) broth, and this was incubated overnight 
at 37ºC. After incubation, the enriched broth culture was 
centrifuged at 13,000 rpm (Sorvall® Biofuge Pico, Germa-
ny) for 1 min and the pellet was heated at 100ºC for 10 min. 
Following centrifugation, 5 µL of the supernatant was used 
in the PCR assays. The PCR assays were performed using 
the primers shown in Table 1. The PCR assays were carried 
out in a 50 µL volume with 2 U DNA Taq polymerase (Taka-
ra Ex TaqTM, Otsu, Japan) in a thermal cycler (PTC-100; MJ 
Research, Watertown, MA, USA). Positive DNA and dis-
tilled water were used as positive and negative controls.
Production of stx1 and stx2 was determined using a re-
versed passive latex agglutination kit (VTEC-RPLA; Den-
ka Seiken Co., Ltd., Tokyo, Japan). One mL of the overnight 
culture was centrifuged and the titer of the supernatant was 
determined using the VTEC-RPLA test, which was per-
formed at dilutions up to 1 : 256. The PCR and RPLA test 
showed that the strain produced only stx2. The adherence A Case of a Shiga Toxin Producing Escherichia Coli
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cytes, and renal tubularcells.12 The HlyA is frequently pro-
duced by E. coli strains that cause urinary tract infections, 
while ehxA is found in the EHEC strains of serogrou-
pO157.10 ClyA is the prototype of pore-forming cytotoxins.18
Although STEC O157:H7 is known to be the predomi-
nant serotype associated with most STEC-related outbreaks 
worldwide, previous epidemiological studies have implied 
that non-O157 STEC infection is becoming problematic in 
public health.19 Among those non-O157 STEC associated 
with human disease are the serotypes O8:H-, O26:H11, 
O91:H21, O103:H2, O111:H-, O113:H21, and O128:H2.1 
The O antigen of the strain was non-typable. From this re-
sult, we suggest that a non-typable serotype might play an 
important role in causing a long-term carrier state. 
There have been several reports of Stx producing E. coli 
and stx2.14 The strain in this study possessed only stx2 gene 
among stx genes (Table 1). 
The stx2 toxin has been described as being 1,000 times 
more cytotoxic than the stx1 toxin, and was related with high 
virulence in STEC strains from HUS patients.15 The adher-
ence of bacteria is important for the infection. Enteropatho-
genic E. coli (EPEC) and EHEC produce an adherence fac-
tor, intimin encoded by the eae gene.16 This gene is detected 
in the locus of enterocyte effacement (LEE), which is re-
quired for attachment-effacement lesions. Another study 
showed that the most widely distributed STEC adhesin gene 
was the iha gene.17 The LEE gene encodes the type III secre-
tion system.4 The strain possessed all the tested genes related 
with the hemolysin. HlyA lyses cells via the creation of pores 
in the cell membrane and this affects erythrocytes, leuko-
Table 1. Detection of Virulence Genes in the Shiga Toxin Producing Escherichia Coli (STEC) Strain Isolated from a Long-Term 
Hospitalized Patient
Description Target genes Primer sequence (5’ to 3’)
Size of PCR 
product (bp)
Presence of 
target gene
Shiga toxin genes stx1
CGTACGGGGATGCAGATAAATCGC   
CAGTCATTACATAAGAACGCCCAC
210 No
stx2
GTTCTGCGTTTTGTCACTGTCAC    
GTCGCCAGTTATCTGACATTCTGG
326 Yes
LEE adhesion genes eaeA
ATGCTGGCATTTGGTCAGGTCGG    
TGACTCATGCCAGCCGCTCATGCG
233 Yes
tir
GCTTGCAGTCCATTGATCCT    
GGGCTTCCGTGATATCTGA
107 Yes
Non-LEE adhesion genes iha
CAGTTCAGTTTCGCATTCACC    
GTATGGCTCTGATGCGATG
1,305 Yes
saa
CGTGATGAACAGGCTATTGC    
ATGGACATGCCTGTGGCAAC
119 No
toxB
ATACCTACCTGCTCTGGATTGA   
TTCTTACCTGATCTGATGCAGC
602 No
efa1
GAGACTGCCAGAGAAAG    
GGTATTGTTGCATGTTCAG
479 No
Type III secretion genes espA
GTTTTTCAGGCTGCGATTCT    
AGTTTGGCTTTCGCATTCTT
187 Yes
espD
AAAAAGCAGCTCGAAGAACA    
CCAATGGCAACAACAGCCCA
145 Yes
espB
GCCGTTTTTGAGAGCCAGAA      
AAAGAACCTAAGATCCCCA
106 Yes
Genes for hemolysin hlyA
GCATCATCAAGCGTACGTTCC    
AATGAGCCAAGCTGGTTAAGCT
519 Yes
ehxA
GGTGCAGCAGAAAAAGTTGTAG     
TCTCGCCTGATAGTGTTTGGTA
1,551 Yes
clyA
GAGGCGAATGATTATGACTG      
ACTTCAGGTACCTCAAAGAG
920 Yes
PCR, polymerase chain reaction; bp, base pair; LEE, locus for enterocyte effacement.Seung-Hak Cho, et al.
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